rhudex
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2007 (NCT00532012)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- T-lymphocyte activation antigen CD80INHIBITOR
CD80 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rhudex
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01500122 | Phase 1 | Dec 1, 2011 | MediGene |
| NCT00704119 | Phase 1 | May 1, 2008 | INC Research, MediGene |
| NCT00532012 | Phase 1 | Sep 1, 2007 | INC Research, MediGene |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MediGene | For profit | 3 | 3 | 1 | 2007 |
| INC Research | For profit | 2 | 0 | 1 | 2007 |
2 organizations
Page 1 / 1